A look back on a successful year – a word from our director
As 2025 draws to a close, the IHI Office is busy wrapping up grant agreements for a series of projects that will start in the new year. We’re also wrapping up a very successful year, with 3 calls launched, 15 projects started, and a wealth of exciting science published.
But publications are just the start; in IHI, first class research is translated into innovative health solutions. Building a solid regulatory strategy into projects is critical for this translation. Recently, a team from the European Medicines Agency and some of our projects shared advice and experiences on how to do this in a webinar. It’s a brilliant introduction to the resources available to projects and applicants – add the recording to your “what-to-watch-over-Xmas list”, it’s a top 2025 title!
Call 12 opens in January and the final call topic texts are now published. For those of you who are assembling a consortium, our IDEHRA project leaders share how they use sports to build commitment and a strong project identity – health research is a team sport and no matter how strong the science, outcomes are shaped by the people enjoying the ride.
Finally, a big thank you to everyone involved in IHI in 2025. IHI is a unique programme – a partnership where people collaborate across competing companies, academia, healthcare and civil society to shape Europe’s future health ecosystem. It is the work of the people in our projects, our member organisations, and in our contributing partners that makes this European programme unique, impactful and globally recognised. I wish you all a wonderful festive season and a restful break.
Niklas Blomberg, IHI Executive Director
But publications are just the start; in IHI, first class research is translated into innovative health solutions. Building a solid regulatory strategy into projects is critical for this translation. Recently, a team from the European Medicines Agency and some of our projects shared advice and experiences on how to do this in a webinar. It’s a brilliant introduction to the resources available to projects and applicants – add the recording to your “what-to-watch-over-Xmas list”, it’s a top 2025 title!
Call 12 opens in January and the final call topic texts are now published. For those of you who are assembling a consortium, our IDEHRA project leaders share how they use sports to build commitment and a strong project identity – health research is a team sport and no matter how strong the science, outcomes are shaped by the people enjoying the ride.
Finally, a big thank you to everyone involved in IHI in 2025. IHI is a unique programme – a partnership where people collaborate across competing companies, academia, healthcare and civil society to shape Europe’s future health ecosystem. It is the work of the people in our projects, our member organisations, and in our contributing partners that makes this European programme unique, impactful and globally recognised. I wish you all a wonderful festive season and a restful break.
Niklas Blomberg, IHI Executive Director
IHI call 12 - read the approved call text
The text of IHI call 12 has been approved by the IHI Governing Board and is now available on the IHI website. The call will be officially launched in mid-January 2026.
Sign up for the IHI Call Days for call 12
The IHI Call Days for call 12 will feature online info sessions on the content (topics), rules and procedures, and financial aspects of the call. Dates: 19-20 January 2026.
Cellular ‘handbrake’ controls cancer drug response, study shows
Scientists identified a key player controlling the production of a building block of DNA – a finding that explains why some cancers are resistant to certain treatments.
Read more
How to build team spirit in your research project – with IDERHA
From cycling to sailing, IDERHA’s leaders regularly use sports at project meetings to build team spirit and highlight the parallels between playing a team sport and collaborating in a public-private partnership.
IHI leading the way in theranostics
IHI projects are positioning Europe as a leader in theranostics, an innovative approach to cancer treatment that could become a gamechanger for people with aggressive cancers.
EASYGEN aims to usher in new era of CAR-T cell therapy
By allowing hospitals to manufacture CAR-T cells in-house, the project hopes to boost access to the promising cancer treatment while cutting costs.
Watch our webinar on regulatory impact and how can you achieve it
Our webinar featured experts from the EMA as well as IHI projects offering advice on the best ways for projects to engage with regulators and achieve regulatory impact.
IHI office closed during end-of-year holidays
The IHI Programme Office will be closed from 24 December 2025 to 4 January 2026 inclusive. During this period, mailboxes will not be checked; queries will be answered when the office reopens on Monday 5 January 2026.
Catch up on our webinar on joining forces to combat TB
Watch our webinar on how projects funded by IMI and EDCTP are advancing the development of a new way of treating tuberculosis (TB).